Prospective phase II study of rituximab with alternating cycles of hyper-CVAD and high-dose methotrexate with cytarabine for young patients with high-risk diffuse large B-cell lymphoma

We conducted a prospective randomized phase II study to evaluate two chemotherapy regimens: (i) rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin and dexamethasone (R-HCVAD) alternating with rituximab, high-dose methotrexate, and cytarabine (R-MA) and (ii) rituximab, cyclop...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Haematol
Main Authors: Oki, Yasuhiro, Westin, Jason R., Vega, Francisco, Chuang, Hubert, Fowler, Nathan, Neelapu, Sattva, Hagemeister, Fredrick B., McLaughlin, Peter, Kwak, Larry W., Romaguera, Jorge E., Fanale, Michelle, Younes, Anas, Rodriguez, Maria Alma, Orlowski, Robert Z., Wang, Michael, Ouzounian, Souzanne T., Samaniego, Felipe, Fayad, Luis
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5278952/
https://ncbi.nlm.nih.gov/pubmed/24117234
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.12585
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados